First identification of the rare FH-Q185R germline mutation in a Chinese HLRCC patient: A case report and literature review

Read full text
Authors: Lu Zhang, Ge Gao, Mengrui Yuan, Haiyan Cui, Mingyu Zhu, Bin Ling, Ling Chen, Hongyi Liu
Cited by: 0
References: 17

Abstract

Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is a rare autosomal dominant disorder caused by the fumarate hydratase (FH) gene mutations. Here, we report the first identification of the rare FH-Q185R mutation in a Chinese patient with HLRCC. This case report not only examines the distribution of the FH gene using the Cancer Genome Atlas database but also provides a series of evidence to assess the pathogenicity of the Q185R mutation. This missense mutation, encoded by mitochondrial DNA, corresponds to the cytoplasmic amino acid residue 142 in human cells. These findings could pave the way for more effective management and treatment approaches for patients suffering from HLRCC.

Fields of Study & Subjects

Renal cell carcinoma treatment Tuberous Sclerosis Complex Research Cancer Hypoxia and Metabolism

Publication details

Journal / source
SAGE Open Medical Case Reports
Volume
14
Pages
2050313X261416788–2050313X261416788
Publication date
1 January 2026
Language
EN